Extract from the Register of European Patents

EP About this file: EP0577716

EP0577716 - NEW NON-ANTICOAGULANT HEPARIN DERIVATIVES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.02.1996
Database last updated on 28.03.2026
Most recent event   Tooltip16.02.1996Application deemed to be withdrawnpublished on 03.04.1996 [1996/14]
Applicant(s)For all designated states
GLYCOMED INCORPORATED
860 Atlantic Avenue Alameda
California 94501 / US
[N/P]
Former [1994/02]For all designated states
GLYCOMED INCORPORATED
860 Atlantic Avenue
Alameda, California 94501 / US
Inventor(s)01 / CONRAD, H. Edward
621 Waterview Isle
Alameda, CA 94501 / US
02 / GUO, Yuchuan
1777 Shoreline Drive, 108A
Alameda, CA 94501 / US
[1994/02]
Representative(s)Goldin, Douglas Michael, et al
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [1994/02]Goldin, Douglas Michael, et al
J.A. KEMP & CO. 14, South Square Gray's Inn
London WC1R 5LX / GB
Application number, filing date92909060.327.03.1992
[1994/02]
WO1992US02517
Priority number, dateUS1991067773729.03.1991         Original published format: US 677737
[1994/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9217188
Date:15.10.1992
Language:EN
[1992/26]
Type: A1 Application with search report 
No.:EP0577716
Date:12.01.1994
Language:EN
The application published by WIPO in one of the EPO official languages on 15.10.1992 takes the place of the publication of the European patent application.
[1994/02]
Search report(s)International search report - published on:US15.10.1992
(Supplementary) European search report - dispatched on:EP05.01.1994
ClassificationIPC:A61K31/725, A61K39/395, C07H5/06, C08B37/10, C07K15/00, C07K15/28
[1994/02]
CPC:
A61K31/715 (EP,US); A61P43/00 (EP); C07K16/18 (EP,US);
C08B37/0075 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   MC,   NL,   SE [1994/02]
TitleGerman:NEUE NICHT-ANTIKOAGULIERENDE HEPARINDERIVATE[1994/02]
English:NEW NON-ANTICOAGULANT HEPARIN DERIVATIVES[1994/02]
French:NOUVEAUX DERIVES DE L'HEPARINE NON ANTICOAGULANTS[1994/02]
Entry into regional phase24.09.1993National basic fee paid 
24.09.1993Search fee paid 
24.09.1993Designation fee(s) paid 
24.09.1993Examination fee paid 
Examination procedure21.09.1992Request for preliminary examination filed
International Preliminary Examining Authority: DE
24.09.1993Examination requested  [1994/02]
03.10.1995Application deemed to be withdrawn, date of legal effect  [1996/14]
06.11.1995Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [1996/14]
Fees paidRenewal fee
28.03.1994Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.03.199504   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]   Y. GUO ET AL.: "The disaccharide composition of heparins and heparan sulfates", ANALYTICAL BIOCHEMISTRY, vol. 176, no. 1, 1989, USA, pages 96 - 104 [A] 1-5 * abstract *
International search[XY]   FEBS Letters, Vol. 97, No. 1, issued January 1979, L. FRANSSON et al., "Relationship Between Anticoagulant Activity of Heparin and Susceptibility to Periodate Oxidation", pages 119-123, see entire document. [X] [Y]
 [XY]   Arzneim.-Forschung/Drug Research, Vol. 36(1), No. 4, issued 1986, B. CASU et al., "Retention of Antilipemic Activity by Periodate-oxidized Non-Anticoagulant Heparins", pages 637-642, see entire document. [X] [Y]
 [Y]   Journal of Cellular Physiology, Vol. 120, issued 1984, J.J. CASTELLOT, Jr. et al., "Structural Determinants of the Capacity of Heparin to Inhibit the Proliferation of Vascular Smooth Muscle Cells", pages 315-320, see entire document. [Y]
 [Y]   Carbohydrate Research, Vol. 80, issued 1980, L. FRANSSON et al., "Periodate Oxidation and Alkaline Degradation of Heparin-related Glycans", pages 131-145, see entire document. [Y]
 [Y]   Archives of Biochemistry and Biophysics, Vol. 240, No. 2, issued 01 August 1985, A.S.B. EDGE et al., "Structural Elucidation of Glycosaminoglycans Through Characterization of Disaccharides Obtained After Fragmentation by Hydrazine-Nitrous Acid Treatment", pages 560-572, see entire document. [Y]
 [Y]   Biochimica et Biophysica Acta, Vol. 760, issued 04 October 1983, V. BUONASSISI et al., "Antibodies to the Heparan Sulfate Proteoglycans Synthesized by Endothelial Cell Cultures", pages 1-12, see entire document. [Y]
 [Y]   Biochemical and Biophysical Research Communications, Vol. 104, No. 1, issued 15 January 1982, P. COLBURN et al., "Anti-Clotting Activity of Endothelial Cell Cultures and Heparan Sulfate Proteoglycans", pages 220-227, see entire document. [Y]
 [Y]   The Journal of Cell Biology, Vol. 102, issued May 1986, J.J. CASTELLOT, Jr. et al., "Structural Determinants of the Capacity of Heparin to Inhibit the Proliferation of Vascular Smooth Muscle Cells. II. Evidence for a Pentasaccharide Sequence that Contains a 3.0 Sulfate Group", pages 1979-1984, see entire [Y]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.